Expert consensus on the management of metabolic diseases in Chinese liver transplant recipients (2019 edition)

Autor: Branch of Organ Transplant Physician of Chinese Medical Doctor Association, Liver Transplantation Group of Branch of Organ Transplantation of Chinese Medical Association

Publikováno v: Qiguan Yizhi, Vol 11, Iss 1, Pp 19-29 (2020)

To further standardize the management of metabolic diseases in liver transplant recipients in China, Expert Consensus on Management of Metabolic Diseases in Liver Transplant Recipients in China (2015 Edition) was revised to Expert Consensus on Manage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::8c27885903a77cb775dcde8628f52bd3
http://www.organtranspl.com/expressnews/detail/qkid/125/id/985.html

Bacterial DNA translocation contributes to systemic inflammation and to minor changes in the clinical outcome of liver transplantation

Autor: Rodríguez-Laiz GP, Zapater P, Melgar P, Alcázar C, Franco M, Giménez P, Pascual S, Bellot P, Palazón JM, Rodríguez M, Carnicer F, MAS P, González-Navajas JM, Gómez L, Such J, Lluís F, FRANCES R, Liver Transplantation Group

Publikováno v: SCIENTIFIC REPORTS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica

Bacterial (bact)DNA is an immunogenic product that frequently translocates into the blood in cirrhosis. We evaluated bactDNA clearance in patients undergoing liver transplantation (LT) and its association with inflammation and clinically relevant com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::27f25391764d5e2d5c20729ef0bde16a
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2947

Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation

Autor: Lodato, F, Berardi, S, Gramenzi, A, Mazzella, G, Lenzi, M, Morelli, Mc, Tame, Mr, Piscaglia, F, Andreone, P, Bologna Liver Transplantation Group (BLTG), [. . ., Ballardini, G, Bernardi, M, Bianchi, Fb, Biselli, M, Bolondi, L, Cescon, M, Colecchia, A, D'Errico, A, Del Gaudio, M, Ercolani, G, Grazi, Gl, Grigioni, W, Lorenzini, S, Pinna, Ad, Ravaioli, M, Roda, E, Sama, C, Vivarelli, M.

Background Treatment of hepatitis C virus (HCV) recurrence after liver transplantation (LT) is difficult with low response rates. Aim To assess the safety and efficacy of pegylated-interferon (PEG-IFN) alfa-2b + ribavirin (RBV) in patients with post-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f670709fff685f9e0f278a7ed1f013
https://hdl.handle.net/11380/1237303

F.N.49 A MODIFIED CHILD–TURCOTTE–PUGH (CTP) FOR SELECTION OF CANDIDATES TO LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD)

Autor: S. Gitto, M. Biselli, A. Gramenzi, R. Di Donato, L. Brodosi, G. Vitale, S. Lorenzini, M. Ravaioli, G.L. Grazi, A.D. Pinna, M. Bernardi, P. Andreone, null Bologna Liver Transplantation Group (BLTG)

Publikováno v: Digestive and Liver Disease. 42:S51

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a20d89851e8b187a5e6bcbead8f0de26
https://doi.org/10.1016/s1590-8658(10)60503-8

Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.

Autor: Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M, Bologna Liver Transplantation Group

Publikováno v: Journal of Clinical Gastroenterology; 2010 Jan, Vol. 44 Issue 1, p52-57, 6p